Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of pre-hospital 600 mg or 900 mg vs. peri-interventional 300 mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial.
Ducci K, Grotti S, Falsini G, Angioli P, Liistro F, Mandò M, Porto I, Bolognese L. Ducci K, et al. Int J Cardiol. 2013 Oct 12;168(5):4814-6. doi: 10.1016/j.ijcard.2013.07.012. Epub 2013 Aug 3. Int J Cardiol. 2013. PMID: 23916779 Clinical Trial. No abstract available.
Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial.
Bolognese L, Falsini G, Liistro F, Angioli P, Ducci K, Taddei T, Tarducci R, Cosmi F, Baldassarre S, Burali A. Bolognese L, et al. Among authors: ducci k. J Am Coll Cardiol. 2006 Feb 7;47(3):522-8. doi: 10.1016/j.jacc.2005.11.012. Epub 2006 Jan 18. J Am Coll Cardiol. 2006. PMID: 16458130 Free article. Clinical Trial.
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Bolognese L, Falsini G, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C. Bolognese L, et al. Among authors: ducci k. J Cardiovasc Med (Hagerstown). 2010 Mar;11(3):199-206. doi: 10.2459/JCM.0b013e32833186a4. J Cardiovasc Med (Hagerstown). 2010. PMID: 19829124 Clinical Trial.
Impact of thrombus aspiration on myocardial tissue reperfusion and left ventricular functional recovery and remodeling after primary angioplasty.
Liistro F, Grotti S, Angioli P, Falsini G, Ducci K, Baldassarre S, Sabini A, Brandini R, Capati E, Bolognese L. Liistro F, et al. Among authors: ducci k. Circ Cardiovasc Interv. 2009 Oct;2(5):376-83. doi: 10.1161/CIRCINTERVENTIONS.109.852665. Epub 2009 Sep 15. Circ Cardiovasc Interv. 2009. PMID: 20031746 Clinical Trial.
Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years.
Liistro F, Fineschi M, Grotti S, Angioli P, Carrera A, Ducci K, Gori T, Falsini G, Pierli C, Bolognese L. Liistro F, et al. Among authors: ducci k. J Am Coll Cardiol. 2010 Feb 16;55(7):613-6. doi: 10.1016/j.jacc.2009.08.075. J Am Coll Cardiol. 2010. PMID: 20170784 Free article.
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C. Bolognese L, et al. Among authors: ducci k. Am J Cardiol. 2012 Jan 1;109(1):67-74. doi: 10.1016/j.amjcard.2011.08.006. Epub 2011 Sep 22. Am J Cardiol. 2012. PMID: 21943940 Clinical Trial.
35 results